Akari Therapeutics to Present at the Jefferies Complement Symposium

NEW YORK and LONDON, April 3, 2017

Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Dr. Gur Roshwalb, Chief Executive Officer, will present at the Jefferies Complement Symposium on April 6, 2017, in Boston, Massachusetts. The company is scheduled to present at 2:10 PM ET.

Click here to see full release